{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:26:28Z","timestamp":1791588388331,"version":"4.3.4"},"reference-count":61,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Debilitating clinical complications in von Willebrand disease (VWD) can affect health\u2010related quality of life (HRQoL), increase healthcare costs and cause long\u2010lasting consequences. However, the magnitude of these burdens needs to be more fully explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To estimate the prevalence and burden of clinical complications, the impact on HRQoL and the economic burden associated with VWD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Embase<jats:sup>\u00ae<\/jats:sup>, MEDLINE<jats:sup>\u00ae<\/jats:sup>, the Cochrane Library and conference proceedings were searched for studies on VWD evaluating clinical complications, HRQoL and cost and resource use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 16 studies assessing clinical complications in VWD, the most prevalent bleeding symptoms were menorrhagia (2%\u201395% [<jats:italic>n<\/jats:italic> =\u00a07 studies]), epistaxis (12%\u201380% [<jats:italic>n<\/jats:italic> =\u00a06]) and easy bruising (46%\u201365% [<jats:italic>n<\/jats:italic> =\u00a02]). Among 17 studies evaluating HRQoL, the most common assessment scales were the generic SF\u201036 (<jats:italic>n<\/jats:italic> =\u00a08 studies) and the EQ\u20105D (<jats:italic>n<\/jats:italic> =\u00a02). Bleeding symptoms were associated with reduced QoL in six of seven studies, and of six studies evaluating treatment impact, four reported improvements in one or more HRQoL components. Among 25 studies on cost and resource use, key observations included higher post\u2010surgery healthcare costs in VWD versus non\u2010VWD patients (<jats:italic>n<\/jats:italic> =\u00a01 study) and higher costs and resource use in VWD patients with bleeding complications versus those without (<jats:italic>n<\/jats:italic> =\u00a01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although limited, available evidence suggests that VWD patients experience a high burden of clinical complications, reduced QoL and high healthcare costs. Haemarthrosis is more common in severe VWD than is often assumed, and bleeds (including haemarthrosis) can reduce QoL. Research efforts to improve QoL and other outcomes should be prioritized.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.14655","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T02:11:04Z","timestamp":1663035064000},"page":"411-422","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical, economic, and health\u2010related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4973-1317","authenticated-orcid":false,"given":"Giancarlo","family":"Castaman","sequence":"first","affiliation":[{"name":"Centre for Bleeding Disorders and Coagulation, Department of Oncology Careggi University Hospital  Firenze Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Katsarou","sequence":"additional","affiliation":[{"name":"Blood Transfusion Centre, National Reference Centre for Congenital Bleeding Disorders Laiko General Hospital  Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Jansen","sequence":"additional","affiliation":[{"name":"CSL Behring  Hattersheim am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Santos","sequence":"additional","affiliation":[{"name":"CSL Behring  Hattersheim am Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin\u00e9s","family":"Escolar","sequence":"additional","affiliation":[{"name":"Department of Haematopathology Hospital Clinic of Barcelona  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-7195","authenticated-orcid":false,"given":"Erik","family":"Berntorp","sequence":"additional","affiliation":[{"name":"Clinical Coagulation Research Unit Lund University  Malm\u00f6 Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601561"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04175.x"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.077263"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13243"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12540"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.12.030"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.20327"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.454.454"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80384-1"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03661.x"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01643.x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003264"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12670"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0793-2"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-016-0389-9"},{"key":"e_1_2_10_18_1","volume-title":"Treatment of Hemophilia A and B and von Willebrand disease","author":"SBU","year":"2012"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2019.04.017"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029616670258"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02563.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12194"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14886"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e328352cafc"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02025.x"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00756.x"},{"issue":"1","key":"e_1_2_10_28_1","first-page":"19","article-title":"Clinical manifestations and complications of von Willebrand disease","volume":"16","author":"Mohsin S","year":"2012","journal-title":"J Rawalpindi Med Coll"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25656"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12014"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02558.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13062"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00447.x"},{"issue":"1","key":"e_1_2_10_34_1","first-page":"53","article-title":"Clinical severity of disease, functional disability and health\u2010related quality of life. Three\u2010year follow\u2010up study of 150 Finnish patients with coagulation disorders","volume":"7","author":"Solovieva S","year":"2001","journal-title":"Haemophilia"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3144"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12561"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00305.x"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13292"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.125.5.547"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S320837"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02022.x"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13149"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.00129.x"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12005"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13473"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0901-5027(89)80026-8"},{"issue":"5","key":"e_1_2_10_47_1","first-page":"391","article-title":"A phase III study comparing secondary long\u2010term prophylaxis versus on\u2010demand treatment with vWF\/FVIII concentrates in severe inherited von Willebrand disease","volume":"17","author":"Peyvandi F","year":"2019","journal-title":"Blood Transfus"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02344.x"},{"key":"e_1_2_10_49_1","first-page":"17","article-title":"Cost\u2010consequence analysis of long\u2010term prophylaxis in the treatment of von Willebrand disease in the Italian context","volume":"7","author":"Schinco P","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1159\/000321767"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.03.009"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02915.x"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-04-0244"},{"issue":"4","key":"e_1_2_10_54_1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2141.2000.02507.x","article-title":"Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease","volume":"111","author":"Lak M","year":"2000","journal-title":"Br J Haematol"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1670704"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12119"},{"key":"e_1_2_10_57_1","first-page":"1","article-title":"von Willebrand's disease in Sweden","volume":"238","author":"Silwer J","year":"1973","journal-title":"Acta Paediatr Scand Suppl"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.168617"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12834"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12995"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000257"},{"issue":"2","key":"e_1_2_10_62_1","first-page":"565","article-title":"von Willebrand disease: proposing definitions for future research","volume":"5","author":"Connell NT","year":"2021","journal-title":"Blood Adv"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14655","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hae.14655","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T11:56:55Z","timestamp":1699012615000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.14655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1111\/hae.14655"],"URL":"https:\/\/doi.org\/10.1111\/hae.14655","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"assertion":[{"value":"2021-11-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}